MS
Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1851
Grab
GRAB
$21.6B
|
MG
Mark Goodridge
| $5.30 | $8.40 |
58%
upside
| Overweight |
24 Jan ‘22
3 years ago |
|
1852
M&T Bank
MTB
$31B
|
KZ
Ken Zerbe
| $198.17 | $185 |
7%
downside
| Equal-Weight |
21 Jan ‘22
3 years ago |
|
1853
Nutanix
NTNX
$20.7B
|
KH
Katy Huberty
| $77.15 | $32 |
59%
downside
| Equal-Weight |
20 Jan ‘22
3 years ago |
|
1854
Crown Holdings
CCK
$11B
|
NK
Neel Kumar
| $94.55 | $135 |
43%
upside
| Overweight |
20 Jan ‘22
3 years ago |
|
1855
Roundhill Ball Metaverse ETF
METV
$324M
|
BN
Brian Nowak
| $19.86 | $395 |
1,889%
upside
| Overweight |
19 Jan ‘22
3 years ago |
|
1856
Cummins
CMI
$55.8B
|
CY
Courtney Yakavonis
| $405.27 | $249 |
39%
downside
| Equal-Weight |
18 Jan ‘22
3 years ago |
|
1857
Sunstone Hotel Investors
SHO
$1.76B
|
TA
Thomas Allen
| $9.31 | $14 |
50%
upside
| Overweight |
18 Jan ‘22
3 years ago |
|
1858
Sportradar
SRAD
$9.25B
|
TA
Thomas Allen
| $31.24 | $19 |
39%
downside
| Equal-Weight |
18 Jan ‘22
3 years ago |
|
1859
Trane Technologies
TT
$92.9B
|
JP
Jashua Pokrzywinski
| $417.32 | $213 |
49%
downside
| Overweight |
14 Jan ‘22
3 years ago |
|
1860
Latham Group
SWIM
$911M
|
JP
Jashua Pokrzywinski
| $7.82 | $25 |
220%
upside
| Equal-Weight |
14 Jan ‘22
3 years ago |
|
1861
Helios Technologies
HLIO
$1.82B
|
JP
Joshua Pokrzywinski
| $54.83 | $97 |
77%
upside
| Equal-Weight |
14 Jan ‘22
3 years ago |
|
1862
Envista
NVST
$3.45B
|
DL
David Lewis
| $20.77 | $45 |
117%
upside
| Equal-Weight |
7 Jan ‘22
3 years ago |
|
1863
Haemonetics
HAE
$2.59B
|
DL
David Lewis
| $53.67 | $60 |
12%
upside
| Equal-Weight |
7 Jan ‘22
3 years ago |
|
1864
Globus Medical
GMED
$7.89B
|
DL
David Lewis
| $58.44 | $82 |
40%
upside
| Equal-Weight |
7 Jan ‘22
3 years ago |
|
1865
Hess Midstream
HESM
$5.18B
|
DM
Devin McDermott
| $39.52 | $32 |
19%
downside
| Equal-Weight |
7 Jan ‘22
3 years ago |
|
1866
Enterprise Products Partners
EPD
$68.5B
|
SB
Stephen Byrd
| $31.65 | $27 |
15%
downside
| Equal-Weight |
7 Jan ‘22
3 years ago |
|
1867
Enliven Therapeutics
ELVN
$1.14B
|
MH
Matthew Harrison
| $19.22 | $16 |
17%
downside
| Equal-Weight |
6 Jan ‘22
3 years ago |
|
|
TECX
1868
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
|
MU
Michael Ulz
| $17.31 | $36 |
108%
upside
| Equal-Weight |
5 Jan ‘22
3 years ago |
|
1869
Nu Holdings
NU
$74.9B
|
JK
Jorge Kuri
| $15.51 | $16 |
3%
upside
| Overweight |
3 Jan ‘22
3 years ago |
|
1870
Revolve Group
RVLV
$1.67B
|
KG
Kimberly Greenberger
| $23.46 | $57 |
143%
upside
| Equal-Weight |
27 Dec ‘21
3 years ago |
|
1871
Quest Diagnostics
DGX
$20.1B
|
CH
Craig Hettenbach
| $180.14 | $159 |
12%
downside
| Equal-Weight |
17 Dec ‘21
3 years ago |
|
1872
F5
FFIV
$18.8B
|
JF
James Faucette
| $326.69 | $280 |
14%
downside
| Overweight |
15 Dec ‘21
3 years ago |
|
1873
Axon Enterprise
AXON
$58.7B
|
JF
James Faucette
| $747.55 | $180 |
76%
downside
| Overweight |
15 Dec ‘21
3 years ago |
|
1874
SL Green Realty
SLG
$4.29B
|
VM
Vikram Malhorta
| $60.47 | $74.20 |
23%
upside
| Equal-Weight |
14 Dec ‘21
3 years ago |
|
1875
CVS Health
CVS
$93.8B
|
CH
Craig Hettenbach
| $73.97 | $125 |
69%
upside
| Overweight |
13 Dec ‘21
3 years ago |
|